This article discusses SEBI's informal guidance regarding the applicability of Business Responsibility and Sustainability Reporting (BRSR) to Nectar Lifesciences Ltd. The company, previously among the top 1000 listed entities, sought clarification on whether BRSR reporting was mandatory after it no longer met the market capitalization threshold. SEBI clarified that continuous compliance with BRSR is required for entities meeting the threshold as of March 31, 2022, and onwards.
In the matter of Nectar Lifesciences Ltd - Dated May 31, 2023.
The Company sought an interpretative letter from the SEBI under the SEBI (LODR) Regulations, with a view to seek clarification for the doubts regarding the applicability of Business Responsibility and Sustainability Reporting (BRSR).
Daily Limit Reached
You have reached your daily limit of 2 Free Articles
Subscribe to
CCI PRO
for unlimited access
Why Upgrade to
CCI PRO?
-
No Ads
-
WhatsApp Broadcasts
-
Daily E-Newsletter
-
Unlimited Articles Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
Buy CCI PRO Now
Already a PRO member?
Login here
for an ad-free experience.
FAQ :
BRSR stands for Business Responsibility and Sustainability Reporting, a requirement mandated by SEBI for certain listed entities.
Generally, the top 1000 listed entities that meet the market capitalization threshold are required to submit BRSR reports from FY 2022-23 onwards.
No, Nectar Lifesciences Ltd was not required to submit a BRSR report because it only qualified as a top 1000 listed entity in the financial year ended March 31, 2021, and not in subsequent years.
The BRSR reporting requirement was mandated for the top 1000 listed entities satisfying the market capitalization criteria from the financial year 2022-23 onwards.
SEBI's guidance was based on Regulation 3(2) of the LODR Regulations and a SEBI Circular dated May 10, 2021, which specify continuous compliance requirements based on market capitalization thresholds.